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The goal of surgical oncology is to remove trapped tumor
cells within lymphatic system at a time when tumor burden
was so small that the chance of systemic dissemination was
believed to be insignificant. Sentinel lymph node biopsy (SNB)
has emerged by the end of the 20th Century to detect micro
metastasis in one or few lymph nodes. SNB is a minimally
invasive procedure that selects patients for complete
lymphadenectomy. Only patients with micro metastasis into
sentinel node (SN) are submitted to complete
lymphadenectomy. Patients without metastasis are preserved,
avoiding complications as infection, parestesia and edema.  It
is one of the most important advances in surgical oncology
and has been adopted by American Joint Committee on Cancer
since 2002 for melanoma and breast cancer staging. SNB has
been checked in others tumors such as those of the
gynecological and gastroenterological areas and those of the
head and neck region.
Since the landmark report by Morton et al in 1992, it has
been confirmed that the sentinel node (SN) status in melanoma
patients very accurately reflects the status of the entire regional
node basin. The SN pathological status is a powerful
prognostic factor, with long term survival rates 30-40% lower
in patients who has micro metastasis into the SN and is the
main predictor of survival outcome in clinically localized
cutaneous melanoma. Therefore, SN assessment is essential
for stratification of patients involved in adjuvant therapy
studies. This minimally invasive technique and its results are
easily reproducible turning it on the standard of care for nodal
staging and a worthwhile procedure.
Trials have been designed to address various questions
about SNB. The Multicenter Selective Lymphadenectomy Trial
is an American trial that will address whether this surgical
strategy provides a survival benefit for patients. The Sunbelt
Melanoma Trial will determine the role of molecular staging in
patients who undergo sentinel lymph node harvest. In another
arm of this study, the role of adjuvant interferon Alfa will be
examined in patients with minimal disease in the regional basin
with just one microscopically positive SLN. The Florida
Melanoma Trial will determine whether all patients with a
positive SLN really need to undergo a complete lymph node
dissection. Clinicians await the results of these three trials to
define the true role of radio guided surgery in patients with
cutaneous melanoma.
Sentinel lymph node procedure involves three phases: 1.
pre-operative lymphoscintigraphy; 2. biopsy of the sentinel
node – by means of vital dye lymphatic mapping and intra-
operative gamma probe detection; 3. histological examination
of the SN. Many questions remain unsolved, such as in which
cases this technique should be indicated (importance of mitotic
rate, vertical growth factor and regression for cutaneous
melanoma); what to do with a specific patient with only one
compromised SN in a few extenstion; what is the clinical
significance of a SN with m-RNA positive thyrosinase by RT-
PCR. On the other hand, this procedure has a low but not
insignificant complication rate. With increasing follow up, false
negative rates are increasing, representing failures of nuclear
medicine and/or surgery and/or pathology. More reliable
techniques in each of these steps and new knowledge achieved
by basic science researches are being investigated objecting
to improve the accuracy of SN identification and pathological
exam. Experimental models of sentinel node biopsy opened a
new frontier in the knowledge of this field such as the
lymphodinamic studies, culture of endothelial lymphatic cells
and the radiopharmaceutical tests. Recently, sonographic
contrast agent has been used to identify SN without operation.
Lymphosonography can be used to detect lymphatic drainage
pathways and SN in a variety of animal models. Magnetic
resonance with Gadomer not only provides excellent
visualization of SN, but also provides the potential for targeted
therapy of SN. In Brazil, the technique has been practiced
since middle of 1990´s and it can be learned in several training
centers like Sentinel Node Laboratory of Plastic Surgery of the
Federal University of São Paulo (UNIFESP), coordinated by
Renato Santos and “Saul Goldenberg Laboratory of Sentinel
Node” of Federal University of Ceará (UFC), coordinated by
Luiz Porto.
 We expect that this new and specific section of Acta
Cirúrgica Brasileira, dedicated exclusively to sentinel node
researches, could be a new channel for publication of advances
in SNB, resulted from activities of researchers located
throughout global community. We hope also, that this Sentinel
Node Section will contribute to the goal of Acta Cirúrgica
Brasileira, to be indexed by the Institute for Scientific
Information at the Web of Science.
